Peripheral neuropathy with myokymia, sustained muscular contraction, and continuous motor unit activity.
D000200:Action Potentials; D000328:Adult; D002118:Calcium / Q000494:pharmacology; D003650:Decamethonium Compounds / Q000494:pharmacology; D003711:Demyelinating Diseases; D004491:Edrophonium / Q000494:pharmacology; D004576:Electromyography; D005260:Female; D006801:Humans; D008278:Magnesium Sulfate / Q000494:pharmacology; D009046:Motor Neurons / Q000503:physiopathology*; D009119:Muscle Contraction; D009132:Muscles / Q000187:drug effects / Q000473:pathology; D009135:Muscular Diseases / Q000209:etiology*; D009388:Neostigmine / Q000494:pharmacology; D009410:Nerve Degeneration; D009431:Neural Conduction; D010525:Peripheral Nerves / Q000473:pathology; D010523:Peripheral Nervous System Diseases / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D010672:Phenytoin / Q000627:therapeutic use; D014403:Tubocurarine / Q000494:pharmacology
D003650:Decamethonium Compounds; D009388:Neostigmine; D010672:Phenytoin; D004491:Edrophonium; D008278:Magnesium Sulfate; D002118:Calcium; D014403:Tubocurarine